[Clinical experiences with preparation Hylakombun in gastroenterology].
D000328:Adult; D000368:Aged; D002986:Clinical Trials as Topic; D003248:Constipation / Q000188:drug therapy; D003967:Diarrhea / Q000188:drug therapy; D004338:Drug Combinations; D004341:Drug Evaluation; D004415:Dyspepsia / Q000188:drug therapy; D005221:Fatigue / Q000188:drug therapy; D001068:Feeding and Eating Disorders / Q000188:drug therapy; D005260:Female; D005414:Flatulence / Q000188:drug therapy; D006356:Heartburn / Q000188:drug therapy; D006801:Humans; D006912:Hydroxyquinolines / Q000627:therapeutic use*; D008286:Malabsorption Syndromes / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009325:Nausea / Q000188:drug therapy; D010146:Pain / Q000188:drug therapy; D010194:Pancreatin / Q000627:therapeutic use*; D010208:Papaverine / Q000627:therapeutic use*; D014839:Vomiting / Q000188:drug therapy
D004338:Drug Combinations; D006912:Hydroxyquinolines; C010197:1-((3,4-diethoxyphenyl)methyl)-6, 5,7-dichloro-8-quinolinol, 7-diethoxyisoquinoline hydrochloride, pancreatin drug combination; D010194:Pancreatin; D010208:Papaverine
Klinische Erfahrungen mit dem Präparat Hylakombun in der Gastroenterologie